The University of Southampton
University of Southampton Institutional Repository

Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children

Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children

Background: Increased anticardiolipin antibody (ACLA) immunoglobulin (Ig) G titers are commonly found in children with arterial ischemic stroke (AIS) or TIA (AIS/TIA). The associated risk of recurrent thromboembolism is unknown. Objective: To determine the risk of recurrent thromboembolism associated with persistently increased ACLA titers of the IgG isotype in children with AIS/TIA. Methods: The authors studied a cohort of children surviving first AIS/TIA tested by standardized ELISA for β2-glycoprotein I-dependent ACLA of the IgG isotype. Children with ACLA. titers >15 IgG phospholipid (GPL) units (per manufacturer's cutoff point) on more than two occasions ≥6 weeks apart were classified as ACLA-positive (ACLA+) and compared with ACLA-negative (ACLA-) children with respect to recurrent thromboembolic events (AIS/TIA, sinovenous thrombosis, and extracerebral thromboembolism). Results: The authors recruited 34 ACLA+ children and 151 ACLA- children. Most ACLA+ children (30/34; 88%) had ACLA titers ≤40 GPL units. During the follow-up period (median duration, 2.8 years for ACLA+ children and 3.0 years for ACLA- children), AIS/TIA recurred in 26% of ACLA+ children and in 38% of ACLA- children; none developed sinovenous thrombosis or extracerebral thromboembolism. Based on survival analysis, this difference was nonsignificant (p = 0.54). Using binary partition evaluation, no titer criteria for ACLA positivity (range, 0 to 60 GPL units) predicted recurrent AIS/TIA. Conclusion: In children surviving arterial ischemic stroke/TIA, increased anticardiolipin antibody immunoglobulin G titers do not predict recurrent thromboembolism.

0028-3878
194-200
Lanthier, S.
7354c56f-a213-46b3-ae20-1006cdb9735c
Kirkham, F. J.
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Mitchell, L. G.
87280d58-014f-41c8-b4ae-3b35f707aa8c
Laxer, R. M.
b9685a2a-0503-4d94-89ae-bcb2d9c5494e
Atenafu, E.
28748387-421b-44a4-93f0-e75798f1f943
Male, C.
f5ccb692-757a-41e9-8cf5-355af32df4c1
Prengler, M.
f5a84d85-bba6-4af4-8437-a003532796e6
Domi, T.
447418c0-4db5-4df1-a5ad-ab8145b2cf7f
Chan, A. K.C.
744fb5f7-ab58-4864-bc5c-f1cbd3d20450
Liesner, R.
38a5a5b9-bfc5-4eb0-b706-21bc552a3e67
DeVeber, G.
850b4d1e-79ec-475f-81d7-c192ce9f9263
Lanthier, S.
7354c56f-a213-46b3-ae20-1006cdb9735c
Kirkham, F. J.
1dfbc0d5-aebe-4439-9fb2-dac6503bcd58
Mitchell, L. G.
87280d58-014f-41c8-b4ae-3b35f707aa8c
Laxer, R. M.
b9685a2a-0503-4d94-89ae-bcb2d9c5494e
Atenafu, E.
28748387-421b-44a4-93f0-e75798f1f943
Male, C.
f5ccb692-757a-41e9-8cf5-355af32df4c1
Prengler, M.
f5a84d85-bba6-4af4-8437-a003532796e6
Domi, T.
447418c0-4db5-4df1-a5ad-ab8145b2cf7f
Chan, A. K.C.
744fb5f7-ab58-4864-bc5c-f1cbd3d20450
Liesner, R.
38a5a5b9-bfc5-4eb0-b706-21bc552a3e67
DeVeber, G.
850b4d1e-79ec-475f-81d7-c192ce9f9263

Lanthier, S., Kirkham, F. J., Mitchell, L. G., Laxer, R. M., Atenafu, E., Male, C., Prengler, M., Domi, T., Chan, A. K.C., Liesner, R. and DeVeber, G. (2004) Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology, 62 (2), 194-200. (doi:10.1212/WNL.62.2.194).

Record type: Article

Abstract

Background: Increased anticardiolipin antibody (ACLA) immunoglobulin (Ig) G titers are commonly found in children with arterial ischemic stroke (AIS) or TIA (AIS/TIA). The associated risk of recurrent thromboembolism is unknown. Objective: To determine the risk of recurrent thromboembolism associated with persistently increased ACLA titers of the IgG isotype in children with AIS/TIA. Methods: The authors studied a cohort of children surviving first AIS/TIA tested by standardized ELISA for β2-glycoprotein I-dependent ACLA of the IgG isotype. Children with ACLA. titers >15 IgG phospholipid (GPL) units (per manufacturer's cutoff point) on more than two occasions ≥6 weeks apart were classified as ACLA-positive (ACLA+) and compared with ACLA-negative (ACLA-) children with respect to recurrent thromboembolic events (AIS/TIA, sinovenous thrombosis, and extracerebral thromboembolism). Results: The authors recruited 34 ACLA+ children and 151 ACLA- children. Most ACLA+ children (30/34; 88%) had ACLA titers ≤40 GPL units. During the follow-up period (median duration, 2.8 years for ACLA+ children and 3.0 years for ACLA- children), AIS/TIA recurred in 26% of ACLA+ children and in 38% of ACLA- children; none developed sinovenous thrombosis or extracerebral thromboembolism. Based on survival analysis, this difference was nonsignificant (p = 0.54). Using binary partition evaluation, no titer criteria for ACLA positivity (range, 0 to 60 GPL units) predicted recurrent AIS/TIA. Conclusion: In children surviving arterial ischemic stroke/TIA, increased anticardiolipin antibody immunoglobulin G titers do not predict recurrent thromboembolism.

This record has no associated files available for download.

More information

Published date: 27 January 2004

Identifiers

Local EPrints ID: 429532
URI: http://eprints.soton.ac.uk/id/eprint/429532
ISSN: 0028-3878
PURE UUID: 7f26d779-c70f-4275-ba88-1fd0b0cbb01c
ORCID for F. J. Kirkham: ORCID iD orcid.org/0000-0002-2443-7958

Catalogue record

Date deposited: 28 Mar 2019 17:30
Last modified: 16 Mar 2024 03:22

Export record

Altmetrics

Contributors

Author: S. Lanthier
Author: F. J. Kirkham ORCID iD
Author: L. G. Mitchell
Author: R. M. Laxer
Author: E. Atenafu
Author: C. Male
Author: M. Prengler
Author: T. Domi
Author: A. K.C. Chan
Author: R. Liesner
Author: G. DeVeber

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×